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Marijuana consumption during adolescence has been proposed to be a stepping stone for adult cocaine addiction. However,
experimental evidence for this hypothesis is missing. In this work we chronically injected male and female Wistar rats with either the
cannabinoid agonist CP 55,940 (CP; 0.4 mg/kg) or its corresponding vehicle. Adult acquisition (seven 30 min daily sessions) and
maintenance (fourteen 2 h daily sessions) of cocaine self administration (1 mg/kg), food reinforced operant learning under conditions of
normal (ad libitum access to food), and high motivation (food restriction schedule) were measured. Additionally, brain metabolic activity
was analyzed by means of [18F] fluorodeoxyglucose positron emission tomography. During the acquisition phase, female CP treated rats
showed a higher rate of cocaine self administration as compared to vehicle treated females and males; no differences were found
between both male groups. This effect disappeared in the maintenance phase. Moreover, no differences among groups were evident in
the food reinforced operant task, pointing to the cocaine specific nature of the effect seen in self administration rather than a general
change in reward processing. Basal brain metabolic activity also changed in CP treated females when compared to their vehicle treated
counterparts with no differences being found in the males; more specifically we observed a hyper activation of the frontal cortex and a
hypo activation of the amygdalo entorhinal cortex. Our results suggest that a chronic exposure to cannabinoids during adolescence alters
the susceptibility to acquire cocaine self administration, in a sex specific fashion. This increased susceptibility could be related to the
changes in brain metabolic activity induced by cannabinoids during adolescence.






















































Epidemiological studies show that the adolescent stage is a
developmental period with increased risk of drug abuse
(Fried et al, 2001; Martin et al, 2002; Patton et al, 2004;
Trad, 1994). Marijuana is widely consumed at this phase of
life (Gruber and Pope, 2002) and there is evidence that
using the drug at this stage could facilitate later drug
abuse, a phenomenon that has been termed the gateway
hypothesis (Kandel et al, 2006). There is a great variability
in human studies in regard to culture, social, and economic
background, and education level of the subjects, thus it is
difficult to establish causal links between adolescent
marijuana consumption and adult drug abuse. Therefore,
experimental studies are needed to clarify this issue
(Kandel, 2003) and they are beginning to shed light on
some aspects of the problem.
For instance, it has been shown that the peripubertal stage
is a critical phase with special neurobehavioral plasticity
and an increased vulnerability to the consequences of
psychoactive drug exposure (Adriani and Laviola, 2004).
Moreover, there is some evidence that a window of high
vulnerability exists during adolescence, especially in the
peripubertal period, where chronic cannabis administration
exerts long-lasting effects on brain and behavior (Schneider
and Koch, 2003; see Viveros et al, 2005 for review). Also, in
a previous work we demonstrated that a chronic exposure
to the cannabinoid agonist CP 55,940 (CP) during puberty
(P35-P45) induced sex-dependent changes in locomotor
activity and anxiety responses that were evident in adult-
hood (Biscaia et al, 2003). Other authors have also reported
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long-term effects of cannabinoids when administered
during adolescence. Schneider and Koch (2003) found
impairments in sensorimotor gating, recognition memory,
and performance in a progressive ratio task when the
cannabinoid was administered specifically during puberty
(P40-P65) but not adulthood. Schneider et al (2005), also
observed alterations in prepulse inhibition and anxiety
responses in adult rats that had been chronically treated
with the cannabinoid agonist WIN 55,212-2 during puberty.
Additionally, it has been reported that the cannabinoid
system is still maturing during adolescence, and that the
density levels (Rodriguez de Fonseca et al, 1993) and mRNA
expression (McLaughlin et al, 1994) of the CB1 receptor
peak between P30 and P40, and then rapidly decline to
reach usual adult values (Rodriguez de Fonseca et al, 1993).
There have been several studies on the possible inter-
actions between cannabinoids and the rewarding actions of
psychostimulants, with no clear conclusions (see Arnold,
2005 for a review). However, most of these experiments
have been performed in adult animals with their cannabi-
noid system already matured. It can be argued that if the
stimulation of the cannabinoid system had occurred earlier
in life, when it was still developing (ie during adolescence),
a more profound alteration of the brain’s neurochemical
messengers would have been evident.
One of the systems that could be affected by a chronic
cannabis exposure is the mesocorticolimbic dopaminergic
system, which is widely involved in reward processing both
in humans (Franken et al, 2005) and animals (Di Chiara
et al, 2004). Supporting this fact, it has been shown that an
adolescent exposure to cannabinoids induces long-lasting
changes in the response to drugs of abuse of rat midbrain
dopamine neurons (Pistis et al, 2004). This sensitization of
the dopaminergic system could provide a mechanistic
explanation for the vulnerability to cocaine addiction shown
by subjects that have consumed cannabinoids during their
adolescence. However, the contribution of other neuro-
chemical systems, such as those of acetylcholine, serotonin,
opioids, and glutamate among others (Adewale et al, 2006;
Negus and Mello, 2002; Smith et al, 2004; Walsh and
Cunningham, 1997), should not be disregarded.
In the experiments reported here, we used [18F]-
fluorodeoxyglucose (FDG) positron emission tomography
(PET) scanning to assess the long-term neural adaptations
induced by the chronic pubertal treatment. This is arguably
the best approach to ascertain general neural metabolic
changes and it has the advantage of having a strong
translational relevance to human studies.
Most of the experimental research in the field of drug
abuse has been carried out on males. However, sex-specific
patterns of consumption during all phases of drug addiction
are well documented (see Lynch, 2006; Roth et al, 2004 for
reviews). So, when designing the study we considered it
interesting to examine potential sex-specific effects of the
cannabinoid administration.
In the present work, we chronically injected male and
female rats with the cannabinoid agonist CP in the
peripubertal stage (P28-P38) of adolescence (Spear, 2000)
and their food and cocaine self-administration behavior
in adulthood was examined. Additionally, brain glucose
metabolism was analyzed by means of PET scanning
using FDG.
MATERIALS AND METHODS
Animals and Drug Administration
We used Wistar albino rats of both sexes. The subjects were
the offspring of rats purchased from Harlan Interfauna
Ibe´rica SA (Barcelona, Spain), which were mated (one
male one female) in our laboratory approximately 2 weeks
after their arrival. All animals were maintained at a constant
temperature (201C) and in a reverse 12-h/12-h dark/light
cycle (lights on at 2000), with free access to food
(commercial diet for rodents A04/A03; Panlab, Barcelona,
Spain) and water unless otherwise specified. On the day of
birth (postnatal day 0), litters were sex balanced and culled
to 1072 pups per dam. The animals were weaned at 22 days
of age.
CP (Tocris) (0.4 mg/kg) or its corresponding vehicle (VH)
(ethanol : cremophor : saline (1 : 1 : 18) cremophor, Fluka
BioChemiKa) was administered i.p., once daily, from day
28 to day 38 (11 injections), at a volume of 2 ml/kg. The
dose of CP was chosen on the basis of our previous study on
the long-term effects of a chronic (P35-P45) CP treatment
(Biscaia et al, 2003). Animals were individually housed and
weighted when they reached P75. All experimental proce-
dures were carried out between 1000 and 1700. The animals
used in this study were maintained in facilities according to
European Union Laboratory Animal Care Rules (86/609/
EEC Directive).
Apparatus
For operant food-reinforced behavior and cocaine self-
administration studies, 12 operant chambers (Coulbourn
Instruments, Allentown, PA, USA) were used. A lever
designed to register a response when 3.0 g of force was
applied was placed on the front wall of the chamber. A
green stimulus light was located above the lever. Food and
cocaine operant data acquisition and storage were accom-
plished on IBM computers (Med Associates, PA, USA).
Imaging was performed with a dedicated small animal
PET scanner (piPET) (Siegel et al, 1999). Tomographic
images were reconstructed using a 3D subset expectation
maximization algorithm (3D-OSEM) (20 iterations, 5
subsets), which results in a spatial resolution of 1.65 mm
full-width at half-maximum (FWHM) isotropic. The useful-
ness of this piPET imaging device has been previously
reported (Jagoda et al, 2004).
Experimental Procedures
The following three experiments were performed and
different sets of animals were used for each one of them.
Fixed-ratio 1 food-reinforced behavior. The experimental
procedures on the first set of animals began when they were
90 days old. Before starting the training, the body weights
of vehicle-exposed (VH) male (n¼ 7) and female (n¼ 9)
rats and CP-exposed (CP) male (n¼ 6) and female (n¼ 12)
rats were reduced to 95–90% of their free-feeding weight.
This food restriction was maintained unless otherwise
stated. This experiment consisted of three consecutive
phases: autoshaping, fixed-ratio 1 (FR1) task with food
restriction, and FR1 task with ad libitum access to food.
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Before the actual FR1 operant task began, animals were
submitted to an autoshaping food-reinforced task consist-
ing of 30 min sessions in which food pellets (45 mg; Noyes
Pellets, Lancaster, NH, USA) were either randomly delivered
in intervals of 60 s average or obtained if the animal emitted
an operant response (ie pressing the lever); a stimulus light
was turned on right before pellet delivery signaling reward
presentation. Animals emitting at least 5 operant responses
were submitted to the first phase of the FR1 food-reinforced
task, which consisted of 30 min sessions for 7 consecutive
days throughout which the animal obtained a food pellet for
each lever press. In this phase the stimulus light signaled
reward availability.
After completing this phase, the animals had ad libitum
access to food for the rest of the experiment. After
recovering their original body weight, animals were
submitted to the same task as in the previous phase for
5 consecutive days.
Cocaine self-administration. When the animals of the
second set (males-VH, n¼ 11, females-VH, n¼ 8; males-CP,
n¼ 10, females-CP, n¼ 7) reached P75 they were food
restricted until they reached between 95–90% of their
original body weight, and were submitted to the same
autoshaping food-reinforced task described above. When
the animals emitted at least five operant responses they
underwent the FR1 food-reinforced task described in the
previous section. When a sufficient (more than 50 responses
per session) and stable (less than 10% variation across three
consecutive sessions) response rate was attained, subjects
were surgically prepared with an intravenous catheter
placed in the jugular vein.
Put briefly, the animals were anesthetized with ketamine
(40 mg/kg i.p.) and diazepam (10 mg/kg i.p.). A polyvi-
nylchloride tubing (0.064 i.d.) was implanted in the right
jugular vein approximately at the level of the atrium. The
catheter was passed subcutaneously and exited in the
midscapular region; it then passed through a spring tether
system (Alice King, Chatham, CA, USA) that was mounted
to the skull of the rat with dental cement. The animals were
given at least 5 days to recover before beginning 5 extra
days of FR1 food-reinforced task previous to the cocaine
self-administration phase. Catheters were flushed daily with
0.5 mm of a solution of antibiotic (gentamicin, 40 mg/ml)
dissolved in heparinized saline to prevent infections and to
maintain catheter patency.
The drug-reinforced behavior study began when the
animals reached P100, and it consisted of two phases. The
first one lasted for 7 consecutive days with 30 min sessions
(acquisition phase), and immediately after finishing this
first part, the animals underwent 14 consecutive daily
sessions of 120 min each (maintenance phase). In each
session an FR1 schedule of reinforcement was followed with
each lever press rendering a 1 mg/kg cocaine injection and
being followed by a 30 s timeout period. A stimulus light
over the lever signaled drug availability.
[18F]-FDG PET scan. Basal brain glucose metabolism was
measured in a third separate set of animals. To obtain brain
metabolism indexes in conditions as similar as possible to
those of cocaine self-administered rats, the animals of this
experiment followed the same food-restriction and auto-
shaping protocol as described in the previous section. When
they were 100 days old, the day before imaging took place, a
catheter was inserted in the femoral vein under continuous
isoflourane anesthesia. Female (193–214 g; CP n¼ 5, VH
n¼ 5) and male (330–370 g; CP n¼ 6, VH n¼ 5) Wistar rats
were then injected with [18F]-FDG (1.83–1.95 mCi). After
35 min of FDG uptake, rats were imaged for 90 min and the
images reconstructed by 3D-OSEM algorithm.
Data Analysis
Body weights. Body weights on the day of individualization
were analyzed with a two-way analysis of variance (ANOVA).
Food-reinforced behavior and cocaine self-administra-
tion. Separate mixed three way ANOVAs were run: one
for the analysis of the food-reinforced task, and another two
for the acquisition and maintenance phases of cocaine
self-administration. ANOVAs included two between-
subjects factors (Sex (male or female) and Treatment (CP
or VH)) and one within-subjects factor (Days). The
dependent variable was the number of reinforcers per
session. Additionally, to have more detailed information of
within-session performance, separate analyses were run for
the first 30, 60, and 90 min of each self-administration
session during the maintenance phase.
Square roots transformations were applied when appro-
priate to correct the skewness in the distribution of the
data and the lack of homogeneity of variances. The level
of significance was set to a¼ 0.05. All calculations were
performed with SPSS 12.0.
PET: statistical parametric mapping. To perform statistical
parametric mapping (SPM) analysis, the reconstructed
image sets were realigned with respect to a [18F]-FDG PET
template by means of a rigid registration algorithm based
on the maximization of mutual information. The template
image was generated by coregistering and averaging
selected images from each vehicle group; a brain mask
was manually segmented on the template and applied to all
registered scans before performing intensity normalization.
The resulting images were smoothed with a Gaussian kernel
(1.5 1.5 3.0 mm FWHM), and analyzed with the SPM5
software, using an ANOVA design to detect differences
between groups. Statistical significance threshold was set to
uncorrected po0.05 and K¼ 10.
RESULTS
Body Weight
No differences due to Treatment or Treatment Sex
interaction were found in the body weight of animals in
the day of individualization. As expected Sex effects were
evident (F1,87¼ 202.389, po0.05) with male rats weighing
more than female ones (MeanMales¼ 289.360 g, SDMales¼
39.01 g; MeanFemales¼ 197.464 g, SDFemales¼ 19.45 g).
Cocaine Self-Administration
Acquisition. The results of the repeated measures ANOVA
showed a statistically significant main effect of the between-
3
subjects factors: Sex (F1.32¼ 13.630, po0.01), Treatment
(F1.32¼ 6.686, po0.05), and the SexTreatment interaction
(F1.32¼ 5.124, po0.05). The analysis of the interaction
revealed a significant main effect of Treatment in females
(F1.13¼ 12.449, po0.01), but not in males, the CP-treated
females self-administering a higher number of injections per
session than their vehicle-treated controls (MeanFemales-CP¼
4.667, SD¼ 1.45; MeanFemales-VH¼ 2.446, SD¼ 1.15) (see
Figure 1a). No effects of the within-subject factor Days were
found indicating a stable acquisition in all groups.
Maintenance. Figure 1b shows the mean number of
injections per session during the maintenance phase. No
effects of the between-subjects factors Sex, Treatment, or
the SexTreatment interaction were found in any of the
time frames analyzed (30, 60, 90, and 120 min). A significant
effect of the within-subjects factor Days was found
(F13.416¼ 2.373, po0.05) indicating a progressive increase
in performance, presumably due to the longer length of
sessions in this phase.
Food-Reinforced Behavior
To test the specificity of the effects observed in cocaine self-
administration, we ran a parallel experiment with food
pellets as reinforcers instead of cocaine infusions. In this
case, as seen in Figure 2, no effect of either the Sex, the
Treatment, or the SexTreatment interaction was evident
neither during the food-restriction phase nor during the ad
libitum phase.
[18F]-FDG PET Scan
The SPM technique showed a significant hypoactivation
of the amygdalo-enthorinal area (t¼ 1.86, po0.05; K¼ 10)
and a hyperactivation of the frontal cortex (t¼ 1.86,
po0.05; K¼ 80) in the CP-treated females as compared to
VH-injected females. No significant differences were found
in males (see Figure 3).
Figure 1 (a) Acquisition of cocaine self administration: mean number of
injections per session across the seven daily acquisition sessions (30 min
duration). As observed female CP treated rats (CP Females) self
administered a higher number of injections per session when compared
to the rest of the groups. No other significant differences were found. The
lack of effect of the Day factor indicates a stable self administration in all
groups. (b) Maintenance of cocaine self administration: performance during
the maintenance phase of cocaine self administration (14 daily sessions of
2 h duration). No differences among groups were found. However the
effect of Days was significant, indicating a progressive increase in the
responses across days, presumably due to the change in the session’s
duration.
Figure 2 FR1 food reinforced operant behavior: food reinforced
behavior during food restriction (a) and ad libitum (b) conditions. The
number of reinforcers earned per session is shown. No differences were
observed in any of the conditions among the groups.
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DISCUSSION
In this work, we have evaluated the long-term effects of a
chronic treatment with the cannabinoid agonist CP during
adolescence (P28-P38) on adult acquisition and mainte-
nance of cocaine self-administration, food-reinforced
operant learning, and brain metabolic activity. During
acquisition, the group of female rats exposed to CP during
puberty exhibited higher adult cocaine self-administration
rates when compared to the other groups. This effect was
not present during maintenance and no other differences
were observed. Additionally, no differences were evident in
the operant food-reinforced task, indicating that the effect
on self-administration rates was specific to cocaine and
not a general change in reward processing. Moreover, the
chronic treatment with CP exerted changes in brain glucose
metabolism in CP-treated females as compared to their
vehicle counterparts. These alterations consisted of a
hyperactivation of the frontal cortex and a hypoactivation
of the amygdalo-enthorinal area. No changes were observed
in males.
As stated in the ‘Introduction’, until very recently the
gateway hypothesis lacked robust experimental validation.
A few studies had examined the causal link between a prior
tetrahydrocannabinol (THC) exposure and a subsequent
enhanced drug self-administration; however, they used
adult THC pre-treated rats that subsequently underwent
heroin or cocaine self-administration (Panlilio et al, 2007;
Solinas et al, 2004). Since these designs did not incorporate
the developmental component that is cardinal to the
gateway hypothesis, a full experimental validation of the
hypothesis was still missing. To our knowledge, the first
time the gateway hypothesis has been confirmed experi-
mentally is that of Ellgren et al (2007) who have reported
higher heroin self-administration rates during adulthood in
male rats treated with THC during adolescence.
In the context of psychostimulants, Ellgren et al (2004)
examined at different periods the effects of amphetamine on
dopamine levels and behavior following cannabinoid
exposure during adolescence. No support for the hypothesis
was found since no changes were observed either in
adolescence or adulthood in dopamine or locomotor
responses to amphetamine.
Although cannabinoids and dopamine have been shown
to interact at several levels (Andersson et al, 2005; Gardner,
2005; Hermann et al, 2002), the relationship between
cannabinoids and the effects of psychostimulant drugs is
currently a matter of debate (see Arnold, 2005 for a review).
For example, Fattore et al (1999) showed that an acute
administration of the cannabinoid agonist WIN 55,512–2
(WIN) decreased cocaine self-administration, and Soria
et al (2005) reported that mice lacking the CB1 receptors
exhibited reduced reinforcing efficacy of cocaine. In
contrast to this, Tanda et al (2000) found that the
administration of the CB1 receptor antagonist rimonabant
(SR141716A) did not affect cocaine self-administration rates
in squirrel monkeys. Additionally, normal behavior in
cocaine self-administration and conditioned place prefer-
ence paradigms has been found in CB1 knockout mice
(Cossu et al, 2001; Martin et al, 2000).
Cocaine is known for exerting both rewarding and
anxiogenic effects (Ettenberg, 2004), so the higher self-
administration rates shown by CP-females in our study
could reflect either an increase in the rewarding actions of
cocaine or a decrement in its anxiogenic effect (Panlilio
et al, 2007). There is evidence that fails to support the
former speculation. First, the chronic CP treatment does not
seem to affect the rewarding values of natural reinforcers
(since no effects were observed in the food-reinforced task),
neither in conditions of high motivation (food deprivation)
nor in normal basal conditions (ad libitum phase). Second,
Ellgren et al (2004) did not find changes in dopamine
release in response to amphetamines after a THC treatment
during adolescence, providing further evidence against a
change in the rewarding/hedonic value of the drug per se.
A change in anxiety responses in CP-treated animals has
been previously reported by our group (Biscaia et al, 2003).
In this study, using the same doses and number of
CP injections, we observed that both female and CP-treated
animals during early adolescence (P35–45) showed dimin-
ished anxiety responses in the elevated plus maze. Although
these effects were additive and not interactive, it can be
Figure 3 Brain glucose metabolism as measured by PET imaging: SPM revealed significant differences in female rats exposed to the cannabinoid agonist
during adolescence. Lower metabolism in amygdalo entorhinal area (left image) and higher metabolism in frontal cortex (right image) of CP Females as
compared to their vehicle treated controls.
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suggested that a higher reduction in anxiety occurred in
CP female rats. This can be hypothesized to be a putative
mechanism explaining our results in the acquisition of
cocaine self-administration. Presumably, CP females might
experience cocaine as less anxiogenic and therefore they
might self-administer more injections of the drug. This
hypothesis needs further experimental testing and CP
should be administered in the same age interval used in
the present study (P28-P38).
An alternative explanation would point to changes in
general locomotor activity that could have been induced by
the treatment in the females; these motor alterations could
result in an elevated frequency of exploratory behavior (and
therefore higher chances of pressing the lever during the
acquisition phase). In this sense, it has been shown that
female rats perinatally exposed to THC showed persistent
changes in spontaneous locomotor activity (Navarro et al,
1994; Rubio et al, 1995). Additionally adult rats treated with
the CB1 agonist WIN exhibited an increased locomotor
activity as measured in the open field, but only at the lowest
dose tested (0.6 mg/kg) (Drews et al, 2005). Although
appealing, this hypothesis is not supported by more specific
experimental work since we have found a decrement rather
than an increment in locomotor activity in CP-treated
females using a very similar design to the one presented
here (Biscaia et al, 2003). Moreover, Schneider et al (2005)
did not find any change in this respect in adult rats treated
with WIN during adolescence.
Surprisingly, we have not observed the typical pattern of
sex differences in self-administration (Lynch, 2006) in the
VH groups (ie females acquiring cocaine self-administra-
tion faster and self-administering higher amounts of the
drug), a fact which might be due, at least in part, to the
particular self-administration schedule used here, and the
dose of cocaine employed. In this sense, it has been recently
reported that sex-differences in cocaine self-administration
disappear when low FR ratios are used and when cocaine
doses are lower than 3 mg/kg (Kantak et al, 2007).
Interestingly, the treatment seemed to boost this latent
sex-specific effect in the acquisition phase.
The chronic treatment employed in this study also
induced changes in brain glucose metabolism. Although
the precise onset of these changes was not evaluated, they
were still evident at the age when self-administration began.
Our data point to a hyperactivation of the frontal cortex and
a hypoactivation of the amygdalo-enthorinal area caused
by the chronic treatment with CP during early adolescence.
In addition, these changes only occurred in CP-treated
females, a fact which parallels our behavioral findings.
The results of the present study differ from those reported
by other groups that have employed whole brain imaging
techniques such as 2-DG autoradiography to measure brain
glucose metabolism. In that kind of studies, a general
reduction in glucose utilization after THC administration
has been consistently reported (Freedland et al, 2003;
Whitlow et al, 2002, 2003). However, in those experiments,
the cannabinoid was always administered in the adult stage,
and on the other hand, the drug used was THC and not CP.
Interestingly, human studies have shown an increased
glucose metabolism in the frontal cortex (Volkow et al,
1991), especially in the right hemisphere after an intra-
venous THC injection. The increased activity found in the
frontal cortex could be derived from the persistent
stimulation of the dopaminergic mesocorticolimbic path-
way caused by the chronic treatment. Thus, the activation of
the cannabinoid receptors has been shown to increase the
activity of meso-prefrontal activity of dopaminergic neu-
rons (Diana et al, 1998). Perhaps, a repetitive stimulation of
the receptor in a particularly plastic stage might have
increased the activity of the frontal cortex in a persistent
fashion. Regarding this possibility, only one report in the
literature has explored the importance of the age of onset of
cannabinoid consumption, and it has been carried out in
human subjects (Wilson et al, 2000). The authors found that
initiating marijuana consumption during adolescence seems
to lead to greater brain cerebral flow alterations induced by
THC. At the behavioral level the hyperactivation of the
frontal cortex seen in CP-treated females could partially
explain (among other behavioral disruptions) their heigh-
tened vulnerability to psychostimulants, due to the im-
portance of this area in the circuitry of drug addiction
(Tzschentke and Schmidt, 2000).
Another interesting finding in the present work is the
hypoactivation seen in the amygdalo-enthorinal area of CP-
treated females as compared to the other groups. This area
is believed to play a role in the storage of long-term
memories before their entry into the perirhinal cortex
where they are thought to be kept for longer periods of time
until recovery (Izquierdo and Medina, 1997). Therefore, a
hypoactivation in this area might indicate some deficits in
long-term memory storage, at least in the first stages of its
initial consolidation. Sim et al (1996) reported decreases in
WIN-stimulated GTPg35S binding in the entorhinal cortex
after a chronic THC treatment. This desensitization of CB1
receptors might account for the hypoactivation observed in
this brain region.
In conclusion, we have shown that a chronic treatment
with a cannabinoid agonist during a specific stage of
adolescence is able to induce behavioral and neural changes
that are still evident in adulthood and that could be
mediating the enhanced vulnerability to cocaine self-
administration seen in female rats pubertally treated with
the cannabinoid agonist CP. The sex-specificity of the
effects needs to be further explored and the role of estrogens
as putative mediators of our findings is currently the focus
of ongoing experiments.
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